Cochlear (ASX:COH) share price sinks 7% on FY24 result
Jaz Harrison
August 15, 2024
The Cochlear Ltd (ASX:COH) share price dropped 7% in response to the company’s FY24 result and FY25 outlook.
Pro Medicus (ASX:PME) share price soars 8% on excellent FY24 result
Jaz Harrison
August 14, 2024
The Pro Medicus Ltd (ASX:PME) share price is up 8% after the ASX healthcare share announced a very strong FY24 result.
CSL (ASX:CSL) share price in focus on 20% profit growth in FY24 result
Jaz Harrison
August 13, 2024
The CSL Ltd (ASX:CSL) share price is in focus after the ASX healthcare share reported its FY24 result, with strong growth.
Ramsay (ASX:RHC) share price down on FY24 earnings update
Jaz Harrison
August 5, 2024
The Ramsay Health Care Ltd (ASX:RHC) share price down 2% after giving an update about items affecting its FY24 result.
Resmed (ASX:RMD) share price in focus on June 2024 result
Jaz Harrison
August 2, 2024
The Resmed Inc (ASX:RMD) share price is under the spotlight today after reporting a strong result for June 2024.
NIB (ASX:NHF) share price drops 3% on CEO retirement
Jaz Harrison
July 29, 2024
The NIB Holdings Limited (ASX:NHF) share price is down 3% after the healthcare business announced the retirement of its CEO.
Is Polynovo Ltd (ASX:PNV) the next Pro Medicus (ASX:PME)?
Rask Australia
July 13, 2024
Is Polynovo Ltd (ASX:PNV) the next Pro Medicus Ltd (ASX: PME)? Owen Rask is back behind the mic for his second solo episode on The Australian Investors Podcast.
Why is Vanguard Australian Shares Index ETF (ASX:VAS) performing so poorly?
Owen Raszkiewicz
June 21, 2024
Is the VAS ETF doing poorly? Why is Vanguard Australian Shares Index ETF (ASX: VAS) performing so poorly?
Telix Pharmaceuticals (ASX:TLX) share price falls after abandoning US listing
Jaz Harrison
June 14, 2024
The Telix Pharmaceuticals Ltd (ASX: TLX) share price is down after shelving its plans to list in the United States.
Cochlear (ASX:COH) share price sinks 7% on FY24 result
August 15, 2024
The Cochlear Ltd (ASX:COH) share price dropped 7% in response to the company’s FY24 result and FY25 outlook.
Pro Medicus (ASX:PME) share price soars 8% on excellent FY24 result
August 14, 2024
The Pro Medicus Ltd (ASX:PME) share price is up 8% after the ASX healthcare share announced a very strong FY24 result.
CSL (ASX:CSL) share price in focus on 20% profit growth in FY24 result
August 13, 2024
The CSL Ltd (ASX:CSL) share price is in focus after the ASX healthcare share reported its FY24 result, with strong growth.
Ramsay (ASX:RHC) share price down on FY24 earnings update
August 5, 2024
The Ramsay Health Care Ltd (ASX:RHC) share price down 2% after giving an update about items affecting its FY24 result.
Resmed (ASX:RMD) share price in focus on June 2024 result
August 2, 2024
The Resmed Inc (ASX:RMD) share price is under the spotlight today after reporting a strong result for June 2024.
NIB (ASX:NHF) share price drops 3% on CEO retirement
July 29, 2024
The NIB Holdings Limited (ASX:NHF) share price is down 3% after the healthcare business announced the retirement of its CEO.
Is Polynovo Ltd (ASX:PNV) the next Pro Medicus (ASX:PME)?
July 13, 2024
Is Polynovo Ltd (ASX:PNV) the next Pro Medicus Ltd (ASX: PME)? Owen Rask is back behind the mic for his second solo episode on The Australian Investors Podcast.
Why is Vanguard Australian Shares Index ETF (ASX:VAS) performing so poorly?
June 21, 2024
Is the VAS ETF doing poorly? Why is Vanguard Australian Shares Index ETF (ASX: VAS) performing so poorly?
Telix Pharmaceuticals (ASX:TLX) share price falls after abandoning US listing
June 14, 2024
The Telix Pharmaceuticals Ltd (ASX: TLX) share price is down after shelving its plans to list in the United States.
Like our podcast? Get Owen's weekly newsletter.
Want to level-up your analytical skills and investing insights but don’t know where to start? We can help. Join 40,000+ Australian investors on our mailing list today and we’ll send you our favourite podcasts, courses, resources, investment articles and podcasts every week. Delivered to your inbox every Sunday morning. Grab a coffee and let Owen and the team bring you the best investment insights every week.